CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients

[1]  Y. Agid,et al.  Dopamine deficiency in the cerebral cortex in Parkinson disease , 1982, Neurology.

[2]  Y. Agid,et al.  Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains , 1982, Brain Research.

[3]  W. Oertel,et al.  Origin of the cholecystokinin-containing fibers in the rat caudatoputamen. , 1982, Science.

[4]  J. Glowinski,et al.  Biochemical investigation on the localization of the cholecystokinin octapeptide in dopaminergic neurons originating from the ventral tegmental area of the rat , 1981, Neuropeptides.

[5]  Y. Agid,et al.  Micro topography of Tyrosine Hydroxylase, Glutamic Acid Decarboxylase, and Choline Acetyltransferase in the Substantia Nigra and Ventral Tegmental Area of Control and Parkinsonian Brains , 1981, Journal of neurochemistry.

[6]  M. Brownstein,et al.  The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay , 1981, Brain Research.

[7]  M. Beinfeld.  An HPLC and RIA analysis of the cholecystokinin peptides in rat brain , 1981, Neuropeptides.

[8]  J. Rehfeld,et al.  A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracing , 1980, Neuroscience.

[9]  J. Rehfeld,et al.  Reduction in cholecystokinin-like immunoreactivity in the basal ganglia in Huntington's disease , 1980, Brain Research.

[10]  P. Dodd,et al.  The depolarization-induced release of cholecystokinin C-terminal octapeptide (CCK-8) from rat synaptosomes and brain slices , 1980, Regulatory Peptides.

[11]  J. D. De Mey,et al.  Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Rehfeld,et al.  Cholecystokinin and vasoactive intestinal polypeptide in the mammalian CNS: distribution and possible physiological roles. , 1980, Advances in biochemical psychopharmacology.

[13]  M. Pinget,et al.  Release of cholecystokinin peptides from a synaptosome-enriched fraction of rat cerebral cortex. , 1979, Life sciences.

[14]  J. Rehfeld,et al.  Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system , 1979, Brain Research.

[15]  M. Runswick,et al.  Isolation, structure and biological activity of two cholecystokinin octapeptides from sheep brain , 1978, Nature.

[16]  J. Rehfeld,et al.  Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. , 1978, The Journal of biological chemistry.

[17]  J. Vanderhaeghen,et al.  Demonstration of biological activity of brain gastrin-like peptidic material in the human: its relationship with the COOH-terminal octapeptide of cholecystokinin. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Yalow,et al.  Immunohistochemical localization in rabbit brain of a peptide resembling the COOH-terminal octapeptide of cholecystokinin. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Dockray,et al.  Immunochemical evidence of cholecystokinin-like peptides in brain , 1976, Nature.

[20]  J. Vanderhaeghen,et al.  New peptide in the vertebrate CNS reacting with antigastrin antibodies , 1975, Nature.

[21]  J. Olszewski,et al.  Cytoarchitecture of the Human Brain Stem , 1955 .